KR102902843B1 - 대칭 디메틸아르기닌의 검출 - Google Patents

대칭 디메틸아르기닌의 검출

Info

Publication number
KR102902843B1
KR102902843B1 KR1020207013888A KR20207013888A KR102902843B1 KR 102902843 B1 KR102902843 B1 KR 102902843B1 KR 1020207013888 A KR1020207013888 A KR 1020207013888A KR 20207013888 A KR20207013888 A KR 20207013888A KR 102902843 B1 KR102902843 B1 KR 102902843B1
Authority
KR
South Korea
Prior art keywords
sdma
mma
antibody
delete delete
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207013888A
Other languages
English (en)
Korean (ko)
Other versions
KR20200073259A (ko
Inventor
홍지 시
스리니바사 라오 라미세티
무르티 브이에스엔 예라밀리
Original Assignee
아이덱스 래보러토리즈, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아이덱스 래보러토리즈, 인코포레이티드 filed Critical 아이덱스 래보러토리즈, 인코포레이티드
Priority to KR1020257007101A priority Critical patent/KR20250034534A/ko
Publication of KR20200073259A publication Critical patent/KR20200073259A/ko
Application granted granted Critical
Publication of KR102902843B1 publication Critical patent/KR102902843B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020207013888A 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출 Active KR102902843B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020257007101A KR20250034534A (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762574592P 2017-10-19 2017-10-19
US62/574,592 2017-10-19
US201762599117P 2017-12-15 2017-12-15
US62/599,117 2017-12-15
PCT/US2018/056687 WO2019079707A1 (en) 2017-10-19 2018-10-19 SYMMETRIC DIMETHYLARGININE DETECTION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020257007101A Division KR20250034534A (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Publications (2)

Publication Number Publication Date
KR20200073259A KR20200073259A (ko) 2020-06-23
KR102902843B1 true KR102902843B1 (ko) 2025-12-19

Family

ID=66170983

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020207013888A Active KR102902843B1 (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출
KR1020257007101A Pending KR20250034534A (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020257007101A Pending KR20250034534A (ko) 2017-10-19 2018-10-19 대칭 디메틸아르기닌의 검출

Country Status (11)

Country Link
US (2) US11422136B2 (https=)
EP (1) EP3697499A4 (https=)
JP (1) JP7398366B2 (https=)
KR (2) KR102902843B1 (https=)
CN (1) CN111246918B (https=)
AU (1) AU2018351349B2 (https=)
CA (1) CA3079011A1 (https=)
MX (1) MX2020003523A (https=)
TW (1) TWI831753B (https=)
WO (1) WO2019079707A1 (https=)
ZA (1) ZA202002415B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2313364T3 (pl) * 2008-08-07 2021-03-08 Idexx Laboratories, Inc. Sposoby wykrywania symetrycznej dimetyloargininy
US10775365B2 (en) 2015-02-20 2020-09-15 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal
AU2018351349B2 (en) 2017-10-19 2025-08-14 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
US10745492B1 (en) * 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
WO2021046339A1 (en) 2019-09-05 2021-03-11 The Regents Of The University Of California Noninvasive method to quantify kidney function and functional decline
CN113125697B (zh) * 2019-12-31 2024-03-26 科美博阳诊断技术(上海)有限公司 一种睾酮均相化学发光检测试剂盒及其应用
US12345641B2 (en) * 2020-04-17 2025-07-01 IDEZZ Laboratories, Inc. Fluorescence quenching immunoassay
EP4263383A4 (en) 2020-12-17 2024-10-23 Nephrosant, Inc. KITS FOR STABILIZATION OF URINE SAMPLES
WO2025070448A1 (ja) * 2023-09-26 2025-04-03 富士フイルム株式会社 対称性ジメチルアルギニンを測定するためのキットおよび対称性ジメチルアルギニンの測定方法
WO2025205769A1 (ja) * 2024-03-26 2025-10-02 富士フイルム株式会社 α－アミラーゼと対称性ジメチルアルギニンとのコンジュゲート、およびその応用
KR102929013B1 (ko) 2025-07-25 2026-02-25 주식회사 아리젠 대칭성 디메틸아르기닌에 특이적으로 결합하는 항체 및 이의 용도

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502948A (ja) 2000-07-06 2004-01-29 ファル　ダイアグノスティクス アルギニン化合物の検出のための方法及びキット
US20100035274A1 (en) * 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for Detecting Symmetrical Dimethylarginine
US20120214978A1 (en) 2011-02-17 2012-08-23 Siemens Healthcare Diagnostics Inc. Reducing Non-Covalently Bound Polysaccharide On Supports
US20160187324A1 (en) 2005-04-28 2016-06-30 Ventana Medical Systems, Inc. Antibody Conjugates
US20160187348A1 (en) 2013-09-05 2016-06-30 Idexx Laboratories, Inc. Methods for Detecting Renal Disease

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875011A (en) 1972-11-06 1975-04-01 Syva Co Enzyme immunoassays with glucose-6-phosphate dehydrogenase
DE3134787A1 (de) 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
IT1199088B (it) 1984-03-09 1988-12-30 Miles Italiana Saggio di legame specifico mediante impiego di anti-g6pdh come marcante
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5710009A (en) * 1994-02-17 1998-01-20 Serex, Inc. Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
US5804452A (en) 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
WO1998049199A1 (en) 1997-05-01 1998-11-05 Panorama Research, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
US6699673B2 (en) 1999-12-22 2004-03-02 The Research Foundation Of State University Of New York Protein methylarginine-specific antibodies
DE60133558D1 (de) 2000-07-12 2008-05-21 Werner Naser Direkte bestimmung des quotients von analyt- zu referenzmolekülen
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
FR2824825B1 (fr) 2001-05-15 2005-05-06 Servier Lab Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
AU2003290784A1 (en) 2002-11-15 2004-06-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
JP2004279412A (ja) * 2003-02-24 2004-10-07 Sanwa Kagaku Kenkyusho Co Ltd 低分子化合物の免疫学的測定・検出方法
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
AU2005231107B8 (en) * 2004-03-30 2011-04-14 Global Life Sciences Solutions Usa Llc Lateral flow format, materials and methods
EP1666884B1 (en) 2004-11-04 2009-04-01 GermedIQ Forschungs- und Entwicklungsgesellschaft mbH Method for determination of arginine, methylated arginines and derivatives thereof
CN1786713A (zh) * 2004-12-09 2006-06-14 陈金华 酶标仪在胶乳增强免疫透射比浊法中的应用
WO2006078813A2 (en) 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
DE102005060057A1 (de) 2005-12-15 2007-06-28 Kellner, Karl-Heinz, Dr. Sandwich-Immunoassay für kleine Haptenmoleküle
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
JP5385914B2 (ja) 2007-12-05 2014-01-08 キングス カレッジ ロンドン 方法及び組成物
CA2763948C (en) 2009-06-02 2019-03-12 Biocrates Life Sciences Ag Combination of amino acids, acylcarnitines and biogenic amines for the assessment of chronic kidney disease
CN101587118B (zh) 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
WO2012029752A1 (ja) 2010-08-31 2012-03-08 コニカミノルタエムジー株式会社 生体物質検出方法
EP2612147B1 (de) 2010-11-17 2016-03-30 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
CN102628868B (zh) 2011-12-30 2014-09-17 北京九强生物技术股份有限公司 检测非对称二甲基精氨酸含量的胶乳增强免疫比浊法试剂盒
EP2802869B1 (en) * 2012-01-10 2018-03-07 IDEXX Laboratories, Inc. Immunoassay test slide
US20140038203A1 (en) 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
ES2822907T3 (es) 2012-08-21 2021-05-05 Janssen Pharmaceutica Nv Haptenos de quetiapina para su uso en inmunoensayos
US10775365B2 (en) 2015-02-20 2020-09-15 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal
AU2018351349B2 (en) 2017-10-19 2025-08-14 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
CN108469419A (zh) * 2018-03-09 2018-08-31 山东泰邦生物制品有限公司 采用酶标仪免疫透射比浊法高通量检测IgG含量的方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502948A (ja) 2000-07-06 2004-01-29 ファル　ダイアグノスティクス アルギニン化合物の検出のための方法及びキット
US20160187324A1 (en) 2005-04-28 2016-06-30 Ventana Medical Systems, Inc. Antibody Conjugates
US20100035274A1 (en) * 2008-08-07 2010-02-11 Idexx Laboratories, Inc. Methods for Detecting Symmetrical Dimethylarginine
US20120214978A1 (en) 2011-02-17 2012-08-23 Siemens Healthcare Diagnostics Inc. Reducing Non-Covalently Bound Polysaccharide On Supports
US20160187348A1 (en) 2013-09-05 2016-06-30 Idexx Laboratories, Inc. Methods for Detecting Renal Disease

Also Published As

Publication number Publication date
CA3079011A1 (en) 2019-04-25
CN111246918A (zh) 2020-06-05
EP3697499A4 (en) 2021-07-21
US20190120856A1 (en) 2019-04-25
EP3697499A1 (en) 2020-08-26
WO2019079707A1 (en) 2019-04-25
JP7398366B2 (ja) 2023-12-14
BR112020007150A2 (pt) 2020-09-24
JP2021500551A (ja) 2021-01-07
KR20250034534A (ko) 2025-03-11
CN111246918B (zh) 2024-06-14
TW201923349A (zh) 2019-06-16
US11422136B2 (en) 2022-08-23
MX2020003523A (es) 2020-07-22
KR20200073259A (ko) 2020-06-23
TWI831753B (zh) 2024-02-11
US20230102277A1 (en) 2023-03-30
AU2018351349B2 (en) 2025-08-14
ZA202002415B (en) 2023-09-27
AU2018351349A1 (en) 2020-04-23

Similar Documents

Publication Publication Date Title
KR102902843B1 (ko) 대칭 디메틸아르기닌의 검출
US20220221446A1 (en) Methods for Detecting Symmetrical Dimethylarginine
JP7282132B2 (ja) 腎疾患の検出方法
US10458981B2 (en) Three-step acid dissociation enzyme linked immunosorbent (TADELIS) assay
TW202204329A (zh) 螢光淬滅免疫分析
WO2011064910A1 (ja) 免疫測定方法
JPH03503566A (ja) 天然結合タンパク質に対するモノクローナル抗体を用いたイムノアツセイ
BR112020007150B1 (pt) Métodos e kit para determinação de dimetilarginina simétrica (sdma) em uma amostra, dispositivo, reagente de captura, fase sólida e composição de um derivado de arginina
WO2011145664A1 (ja) 含硫黄アミノ酸誘導体
JP2003083966A (ja) 抗原／抗体水溶液

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D13-X000 Search requested

St.27 status event code: A-1-2-D10-D13-srh-X000

D14-X000 Search report completed

St.27 status event code: A-1-2-D10-D14-srh-X000

E14-X000 Pre-grant third party observation filed

St.27 status event code: A-2-3-E10-E14-opp-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

A107 Divisional application of patent
J201 Request for trial against refusal decision
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

E12 Pre-grant re-examination requested

Free format text: ST27 STATUS EVENT CODE: A-6-3-E10-E12-REX-PS0901 (AS PROVIDED BY THE NATIONAL OFFICE)

PJ1301 Trial decision

St.27 status event code: A-3-3-V10-V15-crt-PJ1301

Decision date: 20250827

Appeal event data comment text: Appeal Kind Category : Appeal against decision to decline refusal, Appeal Ground Text : 2020 7013888

Appeal request date: 20250304

Appellate body name: Patent Examination Board

Decision authority category: Office appeal board

Decision identifier: 2025101000403

PS0901 Examination by remand of revocation

St.27 status event code: A-6-3-E10-E12-rex-PS0901

V15 Decision substituted

Free format text: ST27 STATUS EVENT CODE: A-3-3-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2025101000403; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : APPEAL AGAINST DECISION TO DECLINE REFUSAL

F13 Ip right granted in full following pre-grant review

Free format text: ST27 STATUS EVENT CODE: A-3-4-F10-F13-REX-PS0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PS0701 Decision of registration after remand of revocation

St.27 status event code: A-3-4-F10-F13-rex-PS0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)